In a murine colon carcinoma model, simultaneous blocking of PD-L1 and CTLA-4 was correlated with an enhanced anti-tumor response [42], indicating the significance of higher expression levels of immunosuppressive surface molecules by Treg also in colon cancer patients. This evidence concerns the gene CD274 and neoplasm.